1. Home
  2. BLCO vs BECN Comparison

BLCO vs BECN Comparison

Compare BLCO & BECN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • BECN
  • Stock Information
  • Founded
  • BLCO 1853
  • BECN 1928
  • Country
  • BLCO Canada
  • BECN United States
  • Employees
  • BLCO N/A
  • BECN N/A
  • Industry
  • BLCO Ophthalmic Goods
  • BECN RETAIL: Building Materials
  • Sector
  • BLCO Health Care
  • BECN Consumer Discretionary
  • Exchange
  • BLCO Nasdaq
  • BECN Nasdaq
  • Market Cap
  • BLCO 6.3B
  • BECN 7.4B
  • IPO Year
  • BLCO 2022
  • BECN 2004
  • Fundamental
  • Price
  • BLCO $15.77
  • BECN $116.64
  • Analyst Decision
  • BLCO Buy
  • BECN Buy
  • Analyst Count
  • BLCO 12
  • BECN 9
  • Target Price
  • BLCO $19.82
  • BECN $120.17
  • AVG Volume (30 Days)
  • BLCO 751.8K
  • BECN 897.4K
  • Earning Date
  • BLCO 02-19-2025
  • BECN 02-27-2025
  • Dividend Yield
  • BLCO N/A
  • BECN N/A
  • EPS Growth
  • BLCO N/A
  • BECN N/A
  • EPS
  • BLCO N/A
  • BECN 5.85
  • Revenue
  • BLCO $4,791,000,000.00
  • BECN $9,659,100,000.00
  • Revenue This Year
  • BLCO $17.29
  • BECN $9.53
  • Revenue Next Year
  • BLCO $5.47
  • BECN $4.28
  • P/E Ratio
  • BLCO N/A
  • BECN $19.94
  • Revenue Growth
  • BLCO 15.56
  • BECN 9.89
  • 52 Week Low
  • BLCO $13.16
  • BECN $77.54
  • 52 Week High
  • BLCO $21.69
  • BECN $121.42
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 32.89
  • BECN 50.61
  • Support Level
  • BLCO $15.62
  • BECN $118.00
  • Resistance Level
  • BLCO $16.60
  • BECN $120.18
  • Average True Range (ATR)
  • BLCO 0.46
  • BECN 1.85
  • MACD
  • BLCO -0.05
  • BECN -0.66
  • Stochastic Oscillator
  • BLCO 7.01
  • BECN 8.60

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About BECN Beacon Roofing Supply Inc.

Beacon Roofing Supply Inc manufactures and sells roofing and building materials throughout the United States and Canada. Beacon's key customers consist of contractors, home builders, lumberyards, retailers, wholesale distributors, and building materials suppliers. The company's product portfolio includes both residential and non-residential roofing materials, siding, windows, and waterproofing systems. The majority of revenue is generated from residential and non-residential roofing products. The vast majority of Beacon's revenue comes from the United States.

Share on Social Networks: